BJDX Stock Summary and Trading Ideas (Bluejay Diagnostics | NASDAQ:BJDX)

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Bluejay Diagnostics trades on the NASDAQ stock market under the symbol BJDX.

As of September 16, 2026, BJDX stock price declined to $0.81 with 114,227 million shares trading.

BJDX has a beta of -1.88, meaning it tends to be less sensitive to market movements. BJDX has a correlation of 0.02 to the broad based SPY ETF.

BJDX has a market cap of $840,706.00. This is considered a Sub-Micro Cap stock.

In the last 3 years, BJDX traded as high as $9,759.84 and as low as $.80.

BJDX has underperformed the market in the last year with a price return of -86.8% while the SPY ETF gained +15.2%. BJDX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -83.1% and -4.1%, respectively, while the SPY returned +0.1% and -1.0%, respectively.

BJDX support price is $.78 and resistance is $.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BJDX shares will trade within this expected range on the day.